Haemonetics Corp. (HAE), a healthcare company, on Thursday announced that net income increased significantly in the fourth quarter compared with the previous year.
For the fourth quarter, net income surged 184.7 percent to $57.98 million from $20.37 million in the prior year.
Earnings per share were $1.17 versus $0.40 last year.
On an adjusted basis, net income came in at $61.57 million from $46.02 million in the previous year.
Adjusted earnings per share were $1.24 versus $0.90 last year.
Ten analysts, on average, had expected the company to report $1.22 per share. Analysts' estimates typically exclude special items.
Operating income increased 138.2 percent to $71.34 million from $29.94 million in the previous year.
Net revenue declined 3.7 percent to $330.6 million from $343.29 million last year.
Looking ahead to the fiscal year 2026, the company expects the adjusted operating margin to range between 26 and 27%. While the adjusted earnings per share are anticipated to range between $4.70 and $5.00.
In the pre-market trading, Haemonetics is 2.41% higher at $65.80 on the New York Stock Exchange.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.